ISSN 2097-6046(网络)
ISSN 2096-7446(印刷)
CN 10-1655/R
主管:中国科学技术协会
主办:中华护理学会
重症护理研究

系统性红斑狼疮患儿行嵌合抗原受体T细胞治疗的护理

  • 费玲 ,
  • 陈秀萍 ,
  • 章毅 ,
  • 杨挺 ,
  • 陈芷涵 ,
  • 诸纪华
展开
  • 310052 杭州市 国家儿童健康与疾病临床医学研究中心/浙江大学医学院附属儿童医院风湿免疫科(费玲,杨挺,陈芷涵),护理部(陈秀萍,诸纪华),神经内科(章毅)
费玲:女,本科(硕士在读),主管护师,护士长,E-mail:370810444@qq.com
诸纪华,E-mail:jihuazhu@zju.edu.cn

收稿日期: 2024-10-15

  网络出版日期: 2025-07-04

Nursing care of a child with systemic lupus erythematosus treated with chimeric antigen receptor T-cells

  • FEI Ling ,
  • CHEN Xiuping ,
  • ZHANG Yi ,
  • YANG Ting ,
  • CHEN Zhihan ,
  • ZHU Jihua
Expand

Received date: 2024-10-15

  Online published: 2025-07-04

摘要

总结1例系统性红斑狼疮患儿开展嵌合抗原受体T细胞免疫疗法(chimeric antigen receptor T-cells,CAR-T)的护理体会。护理要点:输注前成立多学科团队,制订个性化评估表,落实高风险防范措施;精准回输CAR-T细胞,严密监护;输注后加强对细胞因子释放综合征和免疫效应细胞相关神经毒性综合征等不良反应的管理,使患儿顺利度过危险期;同时,关注患儿心理,做好趣味性叙事护理。通过个体化治疗和护理,患儿病情得到有效控制,顺利出院;回输后3个月,系统性红斑狼疮病情活动指数降至0,24 h尿蛋白降至62.5 mg。

本文引用格式

费玲 , 陈秀萍 , 章毅 , 杨挺 , 陈芷涵 , 诸纪华 . 系统性红斑狼疮患儿行嵌合抗原受体T细胞治疗的护理[J]. 中华急危重症护理杂志, 2025 , 6(7) : 853 -855 . DOI: 10.3761/j.issn.2096-7446.2025.07.015

Abstract

To summarize the nursing experience of chimeric antigen receptor T-cell(CAR-T) immunotherapy in a child with systemic lupus erythematosus. The key nursing points included:setting up a multidisciplinary team before infusion to develop a personalized assessment scale and implement high risk prevention,precise reinfusion of CAR T-cells and close monitoring,strengthening the management of adverse reactions such as cytokine release syndrome and immune effector cell-related neurotoxic syndrome after infusion. At the same time,the team paied attention to children’s psychology and did fun narrative nursing. Through individualized treatment and nursing,the child’s condition was effectively controlled and discharged smoothly. Three months after transfusion,the disease activity index of systemic lupus erythematosus decreased to 0,and the 24-hour urine protein decreased to 62.5 mg.

参考文献

[1] 林超群, 王海洪, 沙璐莹, 等. EULAR/ACR-2019、SLICC-2012、ACR-1997三种系统性红斑狼疮分类标准的比较[J]. 实用医学杂志, 2022, 38(1):96-100.
  Lin CQ, Wang HH, Sha LY, et al. Comparison of the clinical value of three classification criteria of systemic lupus erythematosus:ACR-1997,SLICC2012 and EULAR/ACR in 2019[J]. J Pract Med, 2022, 38(1):96-100.
[2] 陈俐, 王雯雯, 吴华香. 嵌合抗原受体T细胞治疗系统性红斑狼疮新进展[J]. 中华风湿病学杂志, 2024, 28(2):139-143.
  Chen L, Wang WW, Wu HX. New progress of chimeric antigen receptor T cells in the treatment of systemic lupus erythematosus[J]. Chin. J. Rheumatol, 2024, 28(2):139-143.
[3] Mougiakakos D, Kr?nke G, V?lkl S, et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus[J]. N Engl J Med, 2021, 385(6):567-569.
[4] Gupta A, Dagar G, Rehmani MU, et al. CAR T-cell therapy in cancer:Integrating nursing perspectives for enhanced patient care[J]. Asia Pac J Oncol Nurs, 2024, 11(10):100579.
[5] 邹波, 杨娉婷. 嵌合抗原受体T细胞疗法在自身免疫性疾病中的应用[J]. 中国实用内科杂志, 2024, 44(6):466-471,477.
  Zou B, Yang PT. Application of chimeric antigen receptor T cell therapy in autoimmune diseases[J]. Chin J Pract Intern Med, 2024, 44(6):466-471,477.
[6] Liu Y, Fang Y, Chen X, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome[J]. Sci Immunol, 2020, 5(43):eaax7969.
文章导航

/